Atlas Trials

Non-Small-Cell Lung

23 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Non-Small-Cell Lung

RecordFirmDate
Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer (NCT04362072)Pfizer2020-09-29
A Study of HLX10 in Combination With Carboplatin Plus (+) Pemetrexed With or Without HLX04 Compared With Carboplatin+Pemetrexed in 1L Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (NCT03952403)Shanghai Henlius Biotech2019-12-02
Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer (NCT03766490)The First Affiliated Hospital of Soochow University2019-03-30
Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy (NCT03626545)Novartis Pharmaceuticals2019-01-23
Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC (NCT03389256)Sichuan Cancer Hospital and Research Institute2018-12-30
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) (NCT03456063)Hoffmann-La Roche2018-04-24
A Clinica Study of Pyrotinib in Patients of Advanced Non-Small Cell Lung Cancer With HER2 Mutation (NCT02834936)Jiangsu HengRui Medicine Co., Ltd.2016-10-20
Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies (NCT01041235)Azaya Therapeutics, Inc.2009-12-01
A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC). (NCT00863746)Bayer2009-04-01
A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NCT00532155)Sanofi2007-09-01
Clinical Impact of EUS in Staging NSCLC (NCT00577746)Indiana University2006-06-01
ZD6474(Vandetanib) + Alimta Combo Study (NCT00506051)Genzyme, a Sanofi Company2005-07-01
Iressa Expanded Access Program (EAP) (NCT00034879)AstraZeneca2000-08-01

Track Non-Small-Cell Lung automatically

Every clearance here is in the API, with alerts when new ones post.